Results 41 to 50 of about 430,860 (160)

A Systematic Review of Clinical and Experimental Periodontitis Studies Demonstrating the Expression of PPAR-Gamma: A Meta-Analysis and Bioinformatics Approach

open access: yesBiomedicines
Aim: Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) plays important anti-inflammatory roles, including in periodontitis. This systematic review with a meta-analysis compiles evidence on the transcriptional and translational levels of PPAR-γ in
Marco Antonio Rimachi Hidalgo   +4 more
doaj   +1 more source

PPAR-γ Activation Exerts an Anti-inflammatory Effect by Suppressing the NLRP3 Inflammasome in Spinal Cord-Derived Neurons

open access: yesMediators of Inflammation, 2019
Persistent inflammation disrupts functional recovery after spinal cord injury (SCI). Peroxisome proliferator-activated receptor gamma (PPAR-γ) activation promotes functional recovery in SCI rats by inhibiting inflammatory cascades and increasing neuronal
Qing-Qi Meng   +6 more
doaj   +1 more source

Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases

open access: yesFrontiers in Pharmacology, 2022
Kidney disease is one of the leading non-communicable diseases related to tremendous health and economic burden globally. Diabetes, hypertension, obesity and cardiovascular conditions are the major risk factors for kidney disease, followed by infections,
Vinesh Sharma   +3 more
doaj   +1 more source

A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses [PDF]

open access: yes, 2016
Background: Persistent fibroblast activation initiated by transforming growth factor β (TGF-β) is a fundamental event in the pathogenesis of systemic sclerosis, and its pharmacological inhibition represents a potential therapeutic strategy.
Doniparthi, Sruthi   +10 more
core   +1 more source

Synthesis of PPAR-γ Activators Inspired by the Marine Natural Product, Paecilocin A

open access: yesMarine Drugs, 2014
A series of N-substituted phthalimide derivatives were synthesized based on a pharmacophore study of paecilocin A (a natural PPAR-γ agonist) and synthetic leads.
Bin Xiao   +7 more
doaj   +1 more source

PPAR-δ agonist affects adipo-chondrogenic differentiation of human mesenchymal stem cells through the expression of PPAR-γ

open access: yesRegenerative Therapy, 2020
Introduction: Peroxisome proliferator–activated receptor (PPAR) subfamily play an important role in chondrogenesis. Previous study has reported that mixture of GW0742 (PPAR-δ agonist), hyaluronic acid (HA) and mesenchymal stem cells (MSCs) enhance ...
Dong Hyun Kim   +5 more
doaj   +1 more source

Peroxisome proliferator-activated receptor-γ agonist 15d-prostaglandin J2 mediates neuronal autophagy after cerebral ischemia-reperfusion injury.

open access: yesPLoS ONE, 2013
Peroxisome proliferator-activated receptor-γ (PPAR-γ) has recently emerged as potential therapeutic agents for cerebral ischemia-reperfusion (I/R) injury because of anti-neuronal apoptotic actions.
Feng Xu   +4 more
doaj   +1 more source

Overexpression of the PPAR‑γ protein in primary Ta/T1 non‑muscle‑invasive urothelial carcinoma [PDF]

open access: yes, 2022
香川県立保健医療大学博士(臨床検査学)application/pdfPeroxisome proliferator‑activated receptor‑γ(PPAR‑γ) is a well‑known nuclear receptor that is activated in the nucleus to regulate several transcription factors.
Yamamoto, Tamami   +7 more
core   +1 more source

QSAR Analysis of 5-Substituted-2-Benzoyl-aminobenzoic acids as PPAR Modulator

open access: yesE-Journal of Chemistry, 2004
A quantitative structure activity relationship (QSAR) study on a series of analogs of 5-aryl thiazolidine-2, 4-diones with activity on PPAR-α and PPAR-γ was made using combination of various thermodynamic, electronic and spatial descriptors.
R. Hemalatha   +3 more
doaj   +1 more source

Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model

open access: yesFrontiers in Physiology, 2018
Renin angiotensin system (RAS) blockade reduces the progression of chronic kidney disease (CKD) independently of its antihypertensive effect. Ang II-induced fibrosis can be mediated by molecules such as klotho, peroxisome proliferator-activate receptor γ
Edgar Maquigussa   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy